HERPES ZOSTER INFECTION IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING TOFACITINIB

被引:0
|
作者
Winthrop, Kevin L.
Melmed, Gil
Vermeire, Severine
Long, Millie D.
Chan, Gary
Pedersen, Ronald D.
Lawendy, Nervin
Thorpe, Andrew J.
Nduaka, Chudy I.
Su, Chinyu
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1748
引用
收藏
页码:S379 / S380
页数:2
相关论文
共 50 条
  • [1] Herpes zoster infection in patients with ulcerative colitis receiving tofacitinib
    Winthrop, K. L.
    Melmed, G. Y.
    Vermeire, S.
    Long, M. D.
    Chan, G.
    Pedersen, R. D.
    Lawendy, N.
    Thorpe, A. J.
    Nduaka, C. I.
    Su, C.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S364 - S364
  • [2] Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib
    Winthrop, Kevin L.
    Melmed, Gil Y.
    Vermeire, Severine
    Long, Millie D.
    Chan, Gary
    Pedersen, Ronald D.
    Lawendy, Nervin
    Thorpe, Andrew J.
    Nduaka, Chudy I.
    Su, Chinyu
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S327 - S328
  • [3] Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib
    Winthrop, Kevin L.
    Melmed, Gil Y.
    Vermeire, Severine
    Long, Millie D.
    Chan, Gary
    Pedersen, Ronald D.
    Lawendy, Nervin
    Thorpe, Andrew J.
    Nduaka, Chudy, I
    Su, Chinyu
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 (10) : 2258 - 2265
  • [4] Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib: An Update as of May 2019
    Winthrop, Kevin L.
    Melmed, Gil Y.
    Vermeire, Severine
    Lawendy, Nervin
    Mundayat, Rajiv
    Kulisek, Nicole
    Su, Chinyu
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S402 - S402
  • [5] Long-term Risk of Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib
    Winthrop, Kevin L.
    Vermeire, Severine
    Long, Millie D.
    Panes, Julian
    Ng, Siew C.
    Kulisek, Nicole
    Mundayat, Rajiv
    Lawendy, Nervin
    Vranic, Ivana
    Modesto, Irene
    Su, Chinyu
    Melmed, Gil Y.
    [J]. INFLAMMATORY BOWEL DISEASES, 2023, 29 (01) : 85 - 96
  • [6] HERPES ZOSTER INFECTION IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING TOFACITINIB: RESULTS FROM THE PHASE 2 AND PHASE 3 CLINICAL PROGRAMS
    Winthrop, Kevin L.
    Melmed, Gil
    Vermeire, Sevenne
    Panes, Julian
    Kulisek, Nicole
    Mundayat, Rajiv
    Lawendy, Nervin
    Su, Chinyu
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S351 - S352
  • [7] Herpes Zoster Infection Followed by Henoch-Schonlein Purpura in a Girl Receiving Infliximab for Ulcerative Colitis
    Nobille, Stefano
    Catassi, Carlo
    Felici, Leonardo
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2009, 15 (02) : 101 - 101
  • [8] Herpes Zoster in Patients Receiving JAK Inhibitors For Ulcerative Colitis: Mechanism, Epidemiology, Management, and Prevention
    Colombel, Jean-Frederic
    [J]. INFLAMMATORY BOWEL DISEASES, 2018, 24 (10) : 2173 - 2182
  • [9] LOWER INCIDENCE OF HERPES ZOSTER IN VEDOLIZUMAB-TREATED VS TOFACITINIB-TREATED PATIENTS WITH ULCERATIVE COLITIS
    Caldera, Freddy
    Lasch, Karen
    Cao, Charlie
    Bhayat, Fatima
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S994 - S994
  • [10] Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program
    Loftus, Edward V., Jr.
    Baumgart, Daniel C.
    Gecse, Krisztina
    Kinnucan, Jami A.
    Connelly, Susan B.
    Salese, Leonardo
    Su, Chinyu
    Kwok, Kenneth K.
    Woolcott, John C.
    Armuzzi, Alessandro
    [J]. INFLAMMATORY BOWEL DISEASES, 2023, 29 (05) : 744 - 751